[ad_1]
Medicaid insurance policies differ from state-to-state. With the appearance of recent, GLP-1 medicines (and others) to deal with weight problems and obese, there are probably vital well being advantages to be gained. Nevertheless, are State Medicaid Businesses really overlaying these medicines? That is the query requested by Liu et al. (2024). They use information from public state Medicaid formulary and most popular drug record recordsdata to find out if a state lined FDA-approved anti-obesity medicines. The variety of reimbursed prescriptions for every antiobesity remedy was recognized from public 2011-2022 Medicaid State Drug Utilization information.
Normally, some however not all anti-obesity medicines are lined. Furthermore, the simpler GLP-1 medicines are sometimes solely lined if they’re used to deal with diabetes (slightly than obese or weight problems).
Within the first quarter of 2023, 10 of 47 states (21%) with public most popular drug lists lined at the least 1 antiobesity remedy; 5 (11%) had unrestricted protection of at the least 1 antiobesity remedy…Individually, 39 states (83%) had unrestricted protection of at the least 1 of the two diabetes variations of GLP-1 RAs.
The total article is right here.
[ad_2]
